RxDoctor Payments Data

Isabella Dimaso, PA

Physician Assistant · Sebastian, FLNPI 1124456116

Payments from drug & device makers

$1,623in general payments, 2019–2025

Across 75 payments — averaging $21.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$183
  • Lilly USA, LLC$175
  • Novo Nordisk$124
  • Exact Sciences$117
  • AbbVie$104
  • GSK$76
  • plus $844 from 25 others

What the payments were for

  • Food & beverage$1,47291%
  • Education$1519%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,623 in reported general payments places this provider in the 70th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$163,853
Medicare patients
500
Services billed
2,317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$102,607
MounjaroTirzepatide42$88,702
EliquisApixaban68$83,935
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$65,179
Soliqua 100-33Insulin Glargine/Lixisenatide23$34,007
MyrbetriqMirabegron24$33,722
TrulicityDulaglutide14$33,632
FarxigaDapagliflozin Propanediol28$30,237
JardianceEmpagliflozin18$28,968
RybelsusSemaglutide11$21,969
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$15,184
Tresiba Flextouch U-200Insulin Degludec12$14,430
LexaproEscitalopram Oxalate17$10,810
Breo ElliptaFluticasone/Vilanterol24$9,715
JanuviaSitagliptin Phosphate11$9,373

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$124$124,57683 claims
Lilly USA, LLCMounjaro, Trulicity$175$122,33456 claims
PfizerEliquis$59$83,93568 claims
GSKTrelegy Ellipta, Breo Ellipta$76$74,89481 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$68$34,00723 claims
Astellas Pharma US IncMyrbetriq$183$33,72224 claims
AstraZenecaFarxiga$42$30,23728 claims
Boehringer IngelheimJardiance$20$28,96818 claims
AbbVieLexapro, Synthroid$104$14,43251 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Sebastian

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →